Maren Drewitz
Papers
1
Total Citations
124
H-Index
1
About
Maren Drewitz is a pioneering researcher in the field of 3D cell culture and tissue engineering, with a primary focus on developing scalable, high-throughput platforms for cancer research and drug testing. Her most-cited work, "Towards automated production and drug sensitivity testing using scaffold‐free spherical tumor microtissues" (2011, 124 citations), addresses a critical bottleneck in translating 3D culture from academic settings to industrial applications. Drewitz’s major contribution lies in advancing scaffold-free spherical microtissue technology, enabling more physiologically relevant tumor models for automated drug sensitivity assays. This work bridges the gap between traditional 2D cultures and complex in vivo systems, offering a reproducible, high-throughput alternative for preclinical screening. Her research has significant implications for personalized medicine and pharmaceutical development, as it improves the predictive accuracy of drug responses while reducing reliance on animal models. By tackling the challenge of industrial scalability, Drewitz has helped pave the way for the broader adoption of 3D culture systems in drug discovery pipelines. Her achievements underscore a commitment to translating innovative tissue engineering solutions into practical, automated tools that can accelerate therapeutic development and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1